Cerebrospinal fluid beta-amyloid and tau proteins for the diagnosis of Alzheimer disease.
- 1 March 2001
- journal article
- editorial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 58 (3) , 349-50
- https://doi.org/10.1001/archneur.58.3.349
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia.Archives of Neurology, 1999